Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lavnish Joshi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Arthritis and Rheumatism|May 1, 2009
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosisSimon R J Taylor, Alan D Salama, Lavnish Joshi, et al.
Inflammation & Allergy Drug Targets|March 12, 2009
Renal & ocular targets for therapy in Wegener's granulomatosisLavnish Joshi, Sally Hamour, Alan D Salama, et al.
Acta Ophthalmologica|December 18, 2012
Dexamethasone implants and neovascular glaucoma in central retinal vein occlusionLavnish Joshi, Oren Tomkins-Netzer, Victor Menezo, et al.
Journal of Autoimmunity|February 12, 2013
SIRT1 activation protects against autoimmune T cell-driven retinal disease in mice via inhibition of IL-2/Stat5 signalingPeter J Gardner, Lavnish Joshi, Richard W J Lee, et al.
Ophthalmology|September 3, 2014
Long-term clinical outcome and causes of vision loss in patients with uveitisOren Tomkins-Netzer, Lazha Talat, Asaf Bar, et al.
BMC Ophthalmology|September 6, 2012
Valacyclovir in the treatment of acute retinal necrosisSimon Rj Taylor, Robin Hamilton, Claire Y Hooper, et al.
Ophthalmology|September 13, 2011
Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effectiveLavnish Joshi, Sue L Lightman, Alan D Salama, et al.
Ophthalmology|January 18, 2014
Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitisLavnish Joshi, Lazha Talat, Satish Yaganti, et al.
The British Journal of Ophthalmology|May 21, 2013
Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-neededLavnish Joshi, Satish Yaganti, Maria Gemenetzi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 2, 2016
Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective studyLavnish Joshi, Asaf Bar, Oren Tomkins-Netzer, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Arthritis and Rheumatism|May 1, 2009
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosisSimon R J Taylor, Alan D Salama, Lavnish Joshi, et al.
Inflammation & Allergy Drug Targets|March 12, 2009
Renal & ocular targets for therapy in Wegener's granulomatosisLavnish Joshi, Sally Hamour, Alan D Salama, et al.
Acta Ophthalmologica|December 18, 2012
Dexamethasone implants and neovascular glaucoma in central retinal vein occlusionLavnish Joshi, Oren Tomkins-Netzer, Victor Menezo, et al.
Journal of Autoimmunity|February 12, 2013
SIRT1 activation protects against autoimmune T cell-driven retinal disease in mice via inhibition of IL-2/Stat5 signalingPeter J Gardner, Lavnish Joshi, Richard W J Lee, et al.
Ophthalmology|September 3, 2014
Long-term clinical outcome and causes of vision loss in patients with uveitisOren Tomkins-Netzer, Lazha Talat, Asaf Bar, et al.
BMC Ophthalmology|September 6, 2012
Valacyclovir in the treatment of acute retinal necrosisSimon Rj Taylor, Robin Hamilton, Claire Y Hooper, et al.
Ophthalmology|September 13, 2011
Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effectiveLavnish Joshi, Sue L Lightman, Alan D Salama, et al.
Ophthalmology|January 18, 2014
Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitisLavnish Joshi, Lazha Talat, Satish Yaganti, et al.
The British Journal of Ophthalmology|May 21, 2013
Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-neededLavnish Joshi, Satish Yaganti, Maria Gemenetzi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 2, 2016
Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective studyLavnish Joshi, Asaf Bar, Oren Tomkins-Netzer, et al.
Pageof 3